NCT02094898View on ClinicalTrials.gov

Ketamine for Depression and Suicide Risk

PHASE2CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions

DepressionSuicide

Interventions

DRUG

Ketamine

0.3 mg/kg/hr of ketamine infused for 100 minutes

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER